Home/Pipeline/AURORA 2 Project Collaboration

AURORA 2 Project Collaboration

Metastatic Breast Cancer

Phase 2Active

Key Facts

Indication
Metastatic Breast Cancer
Phase
Phase 2
Status
Active
Company

About Seqalis

Seqalis is a private, revenue-generating service provider in the diagnostics and genomics sector, operating a specialized laboratory in Belgium. It serves as a contract research organization (CRO) and testing partner for biotech and pharmaceutical companies, offering a suite of technical services including sequencing, histopathology, and custom assay development. The company is actively involved in high-profile research collaborations, such as the AURORA breast cancer project, indicating its role in supporting clinical and translational research. Its business model is focused on providing fee-for-service laboratory analyses and scientific advisory, rather than developing its own therapeutic products.

View full company profile

Therapeutic Areas

Other Metastatic Breast Cancer Drugs

DrugCompanyPhase
ZetaMAST (Zeta-MBC-005)Zetagen TherapeuticsPhase 2
Platin-DRP®Chosa OncologyValidation
Vectorized-VX-765AtlantheraResearch
BPI-1178 (Eciruciclib)Beta PharmaPhase 3
Herzuma®CelltrionMarketed
Eftilagimod alfa (efti)ImmutepPhase IIb
(Z)-endoxifenAtossa TherapeuticsPhase 1/2
Bria-IMT™ + CPIBriaCell TherapeuticsPhase 3
Bria-OTS™ (Bria-BRES™)BriaCell TherapeuticsPhase 1/2